Literature DB >> 9440626

Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C.

A Tran1, G Yang, A Doglio, M Ticchioni, C Laffont, J Durant, J L Bernard, J Gugenheim, M C Saint-Paul, A Bernard, P Rampal, S Benzaken.   

Abstract

The host immune responses have been suggested to play a role in liver injury occurring in patients with chronic hepatitis C. In order to explore the relationship between the relative proportions of intrahepatic and peripheral blood lymphocytes (IHL, PBL), the levels of viremia, and the histological hepatitis activity score, three-color fluorescence-activated cytometric analysis was performed for 36 patients with chronic hepatitis C and six control subjects without chronic hepatitis. The liver biopsy was performed before any antiviral therapy. Each liver specimen was divided into two parts: one for histological examination and one for immunological analysis. Tricolor CD45 was used to improve "lymphogating." Fluorescein isothiocyanate- or phycoerythrin-conjugated monoclonal antibodies with specificity for CD3, CD4, CD8, and CD20 (lymphocyte subpopulations), for CD69 (activated lymphocytes), and for CD16/56 (natural killer cells) were used. The livers of patients with chronic hepatitis C contained a greater proportion of CD4+ lymphocytes that exhibited marked expression of CD69 than in control subjects (20.7 +/- 7.3% vs 10.2 +/- 4.6%, P = 0.027). Moreover, in patients with chronic hepatitis C, the proportion of CD4+ IHL correlated with the histological hepatitis activity evaluated by the Knodell score (r = 0.48, P = 0.004). No correlation was found between the percentage of CD4+ IHL and the level of viremia or transaminase activities. Our findings clearly indicate that a cellular immune response does take place in HCV-infected livers and could thus contribute to the outcome of hepatitis C virus infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440626     DOI: 10.1023/a:1018856410794

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Hepatitis C virus and autoimmunity: fortuitous association or reality?

Authors:  F Lunel
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

2.  T-lymphocyte response to hepatitis C virus in different clinical courses of infection.

Authors:  P Botarelli; M R Brunetto; M A Minutello; P Calvo; D Unutmaz; A J Weiner; Q L Choo; J R Shuster; G Kuo; F Bonino
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

3.  Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.

Authors:  R M Hoffmann; H M Diepolder; R Zachoval; F M Zwiebel; M C Jung; S Scholz; H Nitschko; G Riethmüller; G R Pape
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

4.  Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France.

Authors:  S Ranger; P Martin; M C Roussanne; F Denis
Journal:  Gut       Date:  1993       Impact factor: 23.059

5.  T-cell--mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection.

Authors:  Y F Liaw; C S Lee; S L Tsai; B W Liaw; T C Chen; I S Sheen; C M Chu
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

6.  T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.

Authors:  M Lechmann; H G Ihlenfeldt; I Braunschweiger; G Giers; G Jung; B Matz; R Kaiser; T Sauerbruch; U Spengler
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

7.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.

Authors:  H Schupper; P Hayashi; J Scheffel; S Aceituno; T Paglieroni; P V Holland; J B Zeldis
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

9.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

10.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.

Authors:  M Martell; J I Esteban; J Quer; J Genescà; A Weiner; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more
  8 in total

Review 1.  Review of cytokine profiles in patients with hepatitis.

Authors:  Qiao-Ling Sun; Wei Ran
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

2.  Acute and chronic T cell dynamics in the livers of simian immunodeficiency virus-infected macaques.

Authors:  Muhammad H Ahsan; Amy F Gill; Andrew A Lackner; Ronald S Veazey
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions.

Authors:  M Pernollet; E Jouvin-Marche; V Leroy; I Vigan; J-P Zarski; P N Marche
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

4.  Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.

Authors:  Nidal Muhanna; Sarit Doron; Ori Wald; Amjad Horani; Ahmed Eid; Orit Pappo; Scott L Friedman; Rifaat Safadi
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

Review 5.  Natural killer cells: multifaceted players with key roles in hepatitis C immunity.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

Review 6.  Control of HCV Infection by Natural Killer Cells and Macrophages.

Authors:  Hugo R Rosen; Lucy Golden-Mason
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 5.159

7.  Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Casey Mm Pfluger; Scott R Burrows
Journal:  Mult Scler       Date:  2014-05-19       Impact factor: 6.312

8.  NK cell isolation from liver biopsies: phenotypic and functional analysis of low cell numbers by flow cytometry.

Authors:  Ning Li; Gisella L Puga Yung; Amandine Pradier; Christian Toso; Emiliano Giostra; Isabelle Morard; Laurent Spahr; Jörg D Seebach
Journal:  Front Immunol       Date:  2013-03-11       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.